These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23348707)

  • 1. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats.
    Akash MS; Rehman K; Sun H; Chen S
    Eur J Pharmacol; 2013 Feb; 701(1-3):87-95. PubMed ID: 23348707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats.
    Akash MS; Rehman K; Sun H; Chen S
    PLoS One; 2013; 8(2):e55925. PubMed ID: 23409091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
    Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
    J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.
    Wu L; Olverling A; Fransson L; Ortsäter H; Kappe C; Gao X; Sjöholm A
    Regul Pept; 2012 Aug; 177(1-3):92-6. PubMed ID: 22587909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
    Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
    Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
    Wang X; Lu Q; Yu DS; Chen YP; Shang J; Zhang LY; Sun HB; Liu J
    Chin J Nat Med; 2015 Jul; 13(7):529-34. PubMed ID: 26233843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
    Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
    Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.
    Ehses JA; Lacraz G; Giroix MH; Schmidlin F; Coulaud J; Kassis N; Irminger JC; Kergoat M; Portha B; Homo-Delarche F; Donath MY
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13998-4003. PubMed ID: 19666548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats.
    Domingues N; Pelletier J; Ostenson CG; Castro MM
    J Inorg Biochem; 2014 Feb; 131():115-22. PubMed ID: 24333827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
    George C; Lochner A; Huisamen B
    J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsiate improves glucose metabolism by improving insulin sensitivity better than capsaicin in diabetic rats.
    Kwon DY; Kim YS; Ryu SY; Cha MR; Yon GH; Yang HJ; Kim MJ; Kang S; Park S
    J Nutr Biochem; 2013 Jun; 24(6):1078-85. PubMed ID: 23026494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.
    Luo X; Pan L; Nie A; Wang Q; Gu Y; Li F; Zhang H; Li W; Li X
    J Diabetes; 2013 Dec; 5(4):421-8. PubMed ID: 23590680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto-Kakizaki rats.
    Ouyang X; Li S; Tan Y; Lin L; Yin J; Chen JDZ
    Nutr Diabetes; 2019 Feb; 9(1):4. PubMed ID: 30728346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.